Publikationen von Udo Reichl
Alle Typen
Zeitschriftenartikel (261)
21.
Zeitschriftenartikel
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells 22.
Zeitschriftenartikel
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines 23.
Zeitschriftenartikel
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites 24.
Zeitschriftenartikel
23 (16), 8841 (2022)
Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. International Journal of Molecular Sciences 25.
Zeitschriftenartikel
11 (5), 726 (2021)
Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss. Biomolecules 26.
Zeitschriftenartikel
118 (10), S. 3996 - 4013 (2021)
Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells. Biotechnology and Bioengineering 27.
Zeitschriftenartikel
20 (20), 162 (2021)
Combining functional metagenomics and glycoanalytics to identify enzymes that facilitate structural characterization of sulfated N-glycans. Microbial Cell Factories 28.
Zeitschriftenartikel
342, S. 139 - 148 (2021)
Continuous purification of influenza A virus particles using pseudo-affinity membrane chromatography. Journal of Biotechnology 29.
Zeitschriftenartikel
118 (12), S. 4720 - 4734 (2021)
A high cell density perfusion process for Modified Vaccinia virus Ankara production: process integration with inline DNA digestion and cost analysis. Biotechnology and Bioengineering 30.
Zeitschriftenartikel
16 (1), e2000024 (2021)
Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal 31.
Zeitschriftenartikel
19 (1), 91 (2021)
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles. BMC Biology 32.
Zeitschriftenartikel
105, S. 7251 - 7264 (2021)
Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system. Applied Microbiology and Biotechnology 33.
Zeitschriftenartikel
105 (1), S. 129 - 146 (2021)
OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential. Applied Microbiology and Biotechnology 34.
Zeitschriftenartikel
13 (8), S. 1981 - 1989 (2021)
Multi-enzyme cascades for the in vitro synthesis of guanosine diphosphate L-fucose. ChemCatChem 35.
Zeitschriftenartikel
32 (17-18), S. 959 - 974 (2021)
Single-use capture purification of adeno-associated viral gene transfer vectors by membrane-based steric exclusion chromatography. Human Gene Therapy 36.
Zeitschriftenartikel
13 (17), 9505 (2021)
Integrated Cycles for Urban Biomass as a Strategy to Promote a CO2-Neutral Society—A Feasibility Study. Sustainability 37.
Zeitschriftenartikel
9 (7), 706 (2021)
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines 38.
Zeitschriftenartikel
105 (5), S. 1861 - 1874 (2021)
Tracking changes in adaptation to suspension growth for MDCK cells: cell growth correlates with levels of metabolites, enzymes and proteins. Applied Microbiology and Biotechnology 39.
Zeitschriftenartikel
95 (24), e01174-21 (2021)
Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy. Journal of Virology 40.
Zeitschriftenartikel
288 (16), S. 4869 - 4891 (2021)
Comprehensive N‐glycosylation analysis of the influenza A virus proteins HA and NA from adherent and suspension MDCK cells. The FEBS Journal